Heyiding® is the commercial brand name of Ceftazidime for Injection and 5% Glucose Injection, a third-generation cephalosporin antibiotic developed by Hunan Kelun Pharmaceutical Co., Ltd. It exerts bactericidal effect by inhibiting the synthesis of bacterial cell wall, with stable activity against gram-negative bacteria including Pseudomonas aeruginosa.
Main Indications
Treatment of moderate and severe infections caused by susceptible strains, including lower respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and septicemia.
Clinical Research
A multicenter, randomized, controlled Phase III clinical trial in China verified that this pre-mixed infusion formulation has equivalent efficacy and safety compared with conventional ceftazidime powder for injection in the treatment of moderate to severe bacterial infections;
Clinical evidence demonstrates strong antibacterial activity against common gram-negative pathogens isolated from hospital-acquired infections;
Real-world studies confirm convenient administration while maintaining stable plasma drug concentration, suitable for hospitalized patients.
Common Side Effects
Severe but important risks: Serious allergic reactions, anaphylaxis, pseudomembranous colitis, seizure;
Common mild adverse reactions: Local phlebitis, diarrhea, nausea, rash, and transient elevation of liver enzymes.
Approval Status in China
Original drug Heyiding® (Ceftazidime for Injection and 5% Glucose Injection, specification:1.0g powder plus 50ml 5% glucose solution) was officially approved for marketing in China in 2025. It is currently a prescription cephalosporin antibiotic.
Buy Heyiding (Ceftazidime for Injection and 5% Glucose Injection) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
